Frontier Capital Management’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7,742	Closed	-$442K	–	290
2021 Q1	$442K	Sell	7,742 -70,191	-90%	-$4.01M	﹤0.01%	270
2020 Q4	$6.53M	Sell	77,933 -13,022	-14%	-$1.09M	0.05%	248
2020 Q3	$3.26M	Buy	+90,955	New	+$3.26M	0.03%	274